Terns Pharmaceuticals Net Income Over Time
| TERN Stock | USD 39.45 0.10 0.25% |
With this module, investors can use any or all of fundamental ratio historical patterns as a complementary method for asset selection as well as a tool for deciding entry and exit points. Many technical investors use fundamentals to limit their universe of possible portfolio assets.
Check out Terns Pharmaceuticals Performance and Terns Pharmaceuticals Correlation. Will Pharmaceuticals sector continue expanding? Could Terns diversify its offerings? Factors like these will boost the valuation of Terns Pharmaceuticals. If investors know Terns will grow in the future, the company's valuation will be higher. Accurate valuation requires analyzing both current fundamentals and future growth trajectories. Every Terns Pharmaceuticals data point contributes insight, yet successful analysis hinges on identifying the most consequential variables.
Understanding Terns Pharmaceuticals requires distinguishing between market price and book value, where the latter reflects Terns's accounting equity. The concept of intrinsic value - what Terns Pharmaceuticals' is actually worth based on fundamentals - guides informed investors toward better entry and exit points. Seasoned market participants apply comprehensive analytical frameworks to derive fundamental worth and identify mispriced opportunities. Market sentiment, economic cycles, and investor behavior can push Terns Pharmaceuticals' price substantially above or below its fundamental value.
Please note, there is a significant difference between Terns Pharmaceuticals' value and its price as these two are different measures arrived at by different means. Investors typically determine if Terns Pharmaceuticals is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. In contrast, Terns Pharmaceuticals' trading price reflects the actual exchange value where willing buyers and sellers reach mutual agreement.
Cross Equities Net Income Analysis
Compare Terns Pharmaceuticals and related stocks such as Tourmaline Bio, Oric Pharmaceuticals, and Precigen Net Income Over Time
Select Fundamental| 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ORIC | (22 M) | (22 M) | (22 M) | (22 M) | (22 M) | (22 M) | (22 M) | (22 M) | (21.4 M) | (26.9 M) | (73.7 M) | (77.7 M) | (89.1 M) | (100.7 M) | (127.8 M) | (115.1 M) | (109.3 M) |
| PGEN | (85.3 M) | (85.3 M) | (81.9 M) | (39 M) | (81.8 M) | (84.5 M) | (186.6 M) | (117 M) | (509.3 M) | (170.5 M) | (170.5 M) | (92.2 M) | 28.3 M | (95.9 M) | (126.2 M) | (113.6 M) | (119.3 M) |
| IMTX | (31.4 M) | (31.4 M) | (31.4 M) | (31.4 M) | (31.4 M) | (31.4 M) | (31.4 M) | (31.4 M) | (31.4 M) | (31.7 M) | (229.3 M) | (95.1 M) | 37.5 M | (97 M) | 15.2 M | 17.5 M | 18.4 M |
| ELVN | (11.3 M) | (11.3 M) | (11.3 M) | (11.3 M) | (11.3 M) | (11.3 M) | (11.3 M) | (11.3 M) | (11.3 M) | (23.5 M) | (19 M) | (24.7 M) | (37.7 M) | (71.6 M) | (89 M) | (80.1 M) | (76.1 M) |
| NKTR | (5.3 M) | (134 M) | (171.9 M) | (162 M) | (53.9 M) | (81.2 M) | (153.5 M) | (96.7 M) | 681.3 M | (440.7 M) | (444.4 M) | (523.8 M) | (368.2 M) | (276.1 M) | (119 M) | (107.1 M) | (112.4 M) |
| RLAY | (48.8 M) | (48.8 M) | (48.8 M) | (48.8 M) | (48.8 M) | (48.8 M) | (48.8 M) | (48.8 M) | (48.8 M) | (66.5 M) | (52.4 M) | (363.9 M) | (290.5 M) | (342 M) | (337.7 M) | (303.9 M) | (319.1 M) |
| SNDX | (13.1 M) | (13.1 M) | (10 M) | (14.2 M) | (19.8 M) | (24.1 M) | (44.5 M) | (60.8 M) | (74 M) | (56 M) | (73.1 M) | 24.9 M | (143.7 M) | (209.4 M) | (318.8 M) | (286.9 M) | (272.5 M) |
| INBX | (8.3 M) | (8.3 M) | (8.3 M) | (8.3 M) | (8.3 M) | (8.3 M) | (8.3 M) | (19.4 M) | (31.2 M) | (51.4 M) | (75.6 M) | (81.8 M) | (145.2 M) | (241.4 M) | 1.7 B | 1.9 B | 2 B |
Terns Pharmaceuticals and related stocks such as Tourmaline Bio, Oric Pharmaceuticals, and Precigen Net Income description
Net income is one of the most important fundamental items in finance. It plays a large role in Terns Pharmaceuticals financial statement analysis. It represents the amount of money remaining after all of Terns Pharmaceuticals operating expenses, interest, taxes and preferred stock dividends have been deducted from a company total revenue.My Equities
My Current Equities and Potential Positions
| Terns Pharmaceuticals | TERN |
| Classification | Israel Wall Street |
| Business Address | 1065 East Hillsdale |
| Exchange | NASDAQ Exchange |
USD 39.45
Check out Terns Pharmaceuticals Performance and Terns Pharmaceuticals Correlation. To learn how to invest in Terns Stock, please use our How to Invest in Terns Pharmaceuticals guide.You can also try the Bollinger Bands module to use Bollinger Bands indicator to analyze target price for a given investing horizon.
Terns Pharmaceuticals technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.